Literature DB >> 7370995

In vitro selection of murine B16 melanoma variants with enhanced tissue-invasive properties.

G Poste, J Doll, I R Hart, I J Fidler.   

Abstract

New assay methods have been devised to quantitate tumor cell invasion of tissues of differing histological complexity maintained as organ cultures in vitro (chorioallantoic membrane of chicken, mouse urinary bladder, and canine blood vessel. In addition to quantitating tumor cell invasion, these methods also allow recovery of invasive cells for comparison with noninvasive cells. These methods have been used to select variant sublines from murine B16-F1 and B16-F10 melanoma lines that display significantly greater tissue-invasive abilities than the parent lines. B16 variant sublines selected in vitro for increased invasiveness through the bladder wall or vein also show a significant increase in their ability to form spontaneous and experimental metastases in vivo. In contrast, cells from the same parent cell line selected for increased invasiveness through the chorioallantoic membrane do not show significant alterations in metastatic behavior. We conclude that invasive variants can be isolated from the parent B16 tumor by several in vitro methods and that the level of expression of the invasive phenotype in vivo may be determined by the severity of the selection procedure in vitro.

Entities:  

Mesh:

Year:  1980        PMID: 7370995

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  132 in total

1.  A three-dimensional in-vitro model for the study of peritoneal tumour metastasis.

Authors:  D G Jayne; R O'Leary; A Gill; A Hick; P J Guillou
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

2.  A truncated isoform of the PP2A B56 subunit promotes cell motility through paxillin phosphorylation.

Authors:  A Ito; T R Kataoka; M Watanabe; K Nishiyama; Y Mazaki; H Sabe; Y Kitamura; H Nojima
Journal:  EMBO J       Date:  2000-02-15       Impact factor: 11.598

3.  Selection of brain metastasis-initiating breast cancer cells determined by growth on hard agar.

Authors:  Lixia Guo; Dominic Fan; Fahao Zhang; Janet E Price; Ju-Seog Lee; Dario Marchetti; Isaiah J Fidler; Robert R Langley
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

4.  Localization of the PP2A B56gamma regulatory subunit at the Golgi complex: possible role in vesicle transport and migration.

Authors:  Akihiko Ito; Yu-ichiro Koma; Miwa Sohda; Kenji Watabe; Teruaki Nagano; Yoshio Misumi; Hiroshi Nojima; Yukihiko Kitamura
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

5.  Assay systems for screening food components that have anti-proliferative and anti-invasive activity to rat ascites hepatoma cells: In vitro and ex vivo effects of green tea extract.

Authors:  Y Miura; H Shiomi; F Sakai; K Yagasaki
Journal:  Cytotechnology       Date:  1997-01       Impact factor: 2.058

Review 6.  AACR centennial series: the biology of cancer metastasis: historical perspective.

Authors:  James E Talmadge; Isaiah J Fidler
Journal:  Cancer Res       Date:  2010-07-07       Impact factor: 12.701

7.  A detailed study of the effects of in vitro interferon treatment on the growth of two variants of the B16 mouse melanoma in the lungs: evidence for non-specific effects.

Authors:  M Blackmore; S Thompson; G A Turner
Journal:  Clin Exp Metastasis       Date:  1990 Sep-Oct       Impact factor: 5.150

Review 8.  Invasiveness of transformed bladder epithelial cells.

Authors:  J F Kieler
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

9.  Selection and isolation of a new variant of DBA/2 mastocytoma P 815 X 2.

Authors:  G Bandlow; R Härtl
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

10.  Epigenetic control of the immune escape mechanisms in malignant carcinomas.

Authors:  A Francesca Setiadi; Muriel D David; Robyn P Seipp; Jennifer A Hartikainen; Rayshad Gopaul; Wilfred A Jefferies
Journal:  Mol Cell Biol       Date:  2007-09-17       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.